Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments.

McIntosh SA, Alam F, Adams L, Boon IS, Callaghan J, Conti I, Copson E, Carson V, Davidson M, Fitzgerald H, Gautam A, Jones CM, Kargbo S, Lakshmipathy G, Maguire H, McFerran K, Mirandari A, Moore N, Moore R, Murray A, Newman L, Robinson SD, Segaran A, Soong CN, Walker A, Wijayaweera K, Atun R, Cutress RI, Head MG.
Lancet Oncol
http://www.ncbi.nlm.nih.gov/pubmed/37269844

Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.

Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ.
Nat Med
http://www.ncbi.nlm.nih.gov/pubmed/32555425

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Neftel C, Laffy J, Filbin MG, Hara T, Shore ME, Rahme GJ, Richman AR, Silverbush D, Shaw ML, Hebert CM, Dewitt J, Gritsch S, Perez EM, Gonzalez Castro LN, Lan X, Druck N, Rodman C, Dionne D, Kaplan A, Bertalan MS, Small J, Pelton K, Becker S, Bonal D, Nguyen QD, Servis RL, Fung JM, Mylvaganam R, Mayr L, Gojo J, Haberler C, Geyeregger R, Czech T, Slavc I, Nahed BV, Curry WT, Carter BS, Wakimoto H, Brastianos PK, Batchelor TT, Stemmer-Rachamimov A, Martinez-Lage M, Frosch MP, Stamenkovic I, Riggi N, Rheinbay E, Monje M, Rozenblatt-Rosen O, Cahill DP, Patel AP, Hunter T, Verma IM, Ligon KL, Louis DN, Regev A, Bernstein BE, Tirosh I, SuvĂ  ML.
Cell
http://www.ncbi.nlm.nih.gov/pubmed/31327527